+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-01-19Number of Pages: 93

Facial Injectables Market (Product - Botulinum Toxin, Hyaluronic Acid, Collagen, (Porcine/Bovine-based and Human-based), Particle & Polymer Fillers (PPF) (Polymethylmethacrylate Beads (PMMA microspheres), Poly-L-Lactic Acid, and Calcium Hydroxyapatite; Treatment - Facial Pain, Wrinkle Treatment, and Lip Augmentation; End User - Hospitals, Ambulatory Surgical Centers, Cosmetic Centers, Dermatology Clinics, and Physician Clinics) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

North America Facial Injectables Market: Overview

The demand for facial injectables across North America has been on a continued rise due to changing lifestyles and rising disposable incomes. The increasing focus on physical appearance and aesthetics are also expected to drive the demand for facial injectables in the coming years. The research report states that the North America facial injectables market was valued at US$2.1 bn in 2015 and is expected to reach US$5.8 bn by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to rise at a CAGR of 12.0%. The market for facial injectables in North America has also been gaining momentum due to the increased longevity of the effects of these injectables.
north america facial injectables market

 

Desire to Look Younger Drives North America Facial Injectables Market

Analysts anticipate that the North America facial injectables is expected to receive a significant momentum due to the growing emphasis on physical appearances and the increasing need to reverse the signs of aging. Owing to these reasons, several consumers are spending on facial injectables for cosmetic purposes such as scar lightening, reducing deep lines, and easing out wrinkles. Facial injectables procedures are minimally invasive and thus take lesser recovery time as compared to any other procedures for aesthetics such as face lift surgeries or plastic surgeries. This factor is expected to play a major role in shaping the trajectory of the North America facial injectables market in the near future.

The various products available in the North America facial injectables market are botulinum toxin, hyaluronic acid, collagen, and particle and polymer fillers (PPF). Of these, the botulinum toxin segment held the dominant share in the overall market. The hyaluronic acid segment closely followed this share. Analysts anticipate that the particle and polymer fillers segment is expected to exhibit a steady growth rate during the coming years. The rising demand for botulinum toxin will be attributable to the increasing obsession with physical appearance and desire to look younger.

U.S. to Dominate Overall Market as Consumers Spend Generously on Skin Treatment

In terms of geography, the North America facial injectables market is segmented into Canada and the U.S. According to the research report, the U.S. held the largest share of the North America facial injectables market in 2015. This share was attributable to the increasing expenditure on aesthetic procedures by the consumers in the country. The steady rise in the demand for dermal fillers for anti-aging treatment is expected play an important role in the boosting the North America facial injectables market.

The American Society for Aesthetic Plastic Surgery states that the expenditure on surgical and non-surgical aesthetic procedures across the U.S. stood at US$13.5 bn in 2014, which shows a US$ 1.5 bn rise over that in 2014. Canada will also follow this trend in the coming years. Analysts predict that the number of patients will skin issues will continue to remain on the rise across North America, which, in turn, will boost the uptake of non-surgical procedures in the region.

The key players operating in the North America facial injectables market are Allergan Plc, Galderma S.A. (Nestle), Merz Pharma & Co. KGaA, Prollenium Medical Technologies Inc., Ipsen Group, and Bloomage BioTechnology Corporation Limited. Of these, Allergan Plc held a dominant share in the overall market, making the competitive landscape fairly monopolistic in nature.

Chapter 1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology 
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary
3.1. North America facial injectables market: Market Snapshot
3.2. Market Share Analysis by country, 2015

Chapter 4. Market Overview
4.1. Product Overview
4.2. North America facial injectables market : Key Industry Events
4.3. North America Facial Injectables Market Size (US$ Mn) Forecast, 2014–2024
4.4. North America Facial Injectables Market Outlook
4.5. Porter’s Five Forces Analysis

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
       5.2.1. Enhanced longevity of the effects to augment demand for facial injectables
       5.2.2. Improving lifestyles and rising inclination toward minimally invasive surgeries 
       5.2.3. Growing global obsession with physical appearance and the desire to look young
       5.2.4. Escalating number of patients with various cosmetic skin problems such as scars, deep lines, and wrinkles 
       5.2.5. Increased rate of spending on esthetic procedures
5.3. Restraints
       5.3.1. Side-effects of available products limiting adoption
       5.3.2. Lack of appropriate reimbursement policies supporting cosmetic procedures
       5.3.3. High cost of treatment
5.4. Opportunities
       5.4.1. Product innovation and process development to overcome disadvantages of commercially available products
       5.4.2. New tools and smartphone applications that aid the purchasing process are likely to be created and used by consumers
5.5. Key Trends

Chapter 6. North America Facial Injectables Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. North America Facial Injectables Market Value Share Analysis, by Product Type
6.4. North America Facial Injectables Market Analysis, by Product Type 
       6.4.1. Botulinum Toxin
       6.4.2. Hyaluronic Acid
       6.4.3. Collagen
                6.4.3.1. Porcine/ Bovine-Based
                6.4.3.2. Human Based
       6.4.4. Particle & Polymer Fillers (PPF)
                6.4.4.1. Polymethylmethacrylate Beads (PMMA microspheres)
                6.4.4.2. Poly-L-Lactic Acid
                6.4.4.3. Calcium Hydroxyapatite 
6.5. North America Facial Injectables Market Attractiveness Analysis, by Product
6.6. Key Trends

Chapter 7. North America Facial Injectables Market Analysis, by Treatment Type
7.1. Key Findings
7.2. Introduction
7.3. North America Facial Injectables Market Value Share Analysis, by Treatment
7.4. North America Facial Injectables Market Analysis, by Treatment
       7.4.1. Facial Pain
       7.4.2. Wrinkle Treatment
       7.4.3. Lip Augmentation
       7.4.4. Others
7.5. North America Facial Injectables Market Attractiveness Analysis, by Treatment
7.6. Key Trends

Chapter 8. North America Facial Injectables Market Analysis, by End user
8.1. Key Findings
8.2. Introduction
8.3. North America Facial Injectables Market Value Share Analysis, by End User
8.4. North America Facial Injectables Market Analysis, by End User
       8.4.1. Hospitals
       8.4.2. Ambulatory Surgical Centers
       8.4.3. Cosmetic Centers
       8.4.4. Dermatology Clinics
       8.4.5. Physician Clinics 
8.5. North America Facial Injectables Market Attractiveness Analysis, by End User
8.6. Key Trends

Chapter 9. North America Facial Injectables Market Analysis, by Country
9.1. North America Facial Injectables Market Value Share Analysis, by Country 
9.2. North America Facial Injectables Market Forecast, by Country 
9.3. North America Facial Injectables Market Attractiveness Analysis, by Country
9.4. Market Trends 

Chapter 10. Company Profiles
10.1. North America Facial Injectables Market Share Analysis, by Company (2015)
10.2. Competition Matrix
10.3. Company Profiles
       10.3.1. Allergan plc.
                10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.1.2. Financial Overview
                10.3.1.3. Product Portfolio
                10.3.1.4. SWOT Analysis
                10.3.1.5. Strategic Overview
       10.3.2. Galderma S.A. (Nestle)
                10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.2.2. Financial Overview
                10.3.2.3. Product Portfolio
                10.3.2.4. SWOT Analysis
                10.3.2.5. Strategic Overview
       10.3.3. Merz Pharma & Co. KGaA
                10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.3.2. Financial Overview
                10.3.3.3. Product Portfolio
                10.3.3.4. SWOT Analysis
                10.3.3.5. Strategic Overview
       10.3.4. Prollenium Medical Technologies Inc.
                10.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.4.2. Financial Overview
                10.3.4.3. Product Portfolio
                10.3.4.4. SWOT Analysis
                10.3.4.5. Strategic Overview
       10.3.5. Ipsen Group
                10.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.5.2. Financial Overview
                10.3.5.3. Product Portfolio
                10.3.5.4. SWOT Analysis
                10.3.5.5. Strategic Overview
       10.3.6. Bloomage BioTechnology Corporation Limited 
                10.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.6.2. Financial Overview
                10.3.6.3. Product Portfolio
                10.3.6.4. SWOT Analysis
                10.3.6.5. Strategic Overview

List of Figures

Figure 1: North America Facial Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
Figure 2: North America Facial Injectables Market Value Share, by Product Type, 2016 and 2024
Figure 3: North America Botulinum Toxin Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 4: North America Hyaluronic Acid Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 5: North America Collagen Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 6: North America Particles and Polymer Fillers (PPF) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 7: Facial Injectables Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 8: North America Facial Injectables Market Value Share, by Treatment Type, 2016 and 2024
Figure 9: North America Facial Pain Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 10: North America Wrinkle Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 11: North America Lip Augmentation Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 12: North America Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 13: Facial Injectables Market Attractiveness Analysis, by Treatment Type, 2016–2024
Figure 14: North America Facial Injectables Market Value Share, by End-user, 2016 and 2024
Figure 15: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2014–2024
Figure 16: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2014–2024
Figure 17: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetic Centers, 2014–2024
Figure 18: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Dermatology Clinics, 2014–2024
Figure 19: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician Clinics, 2014–2024
Figure 20: North America Facial Injectables Market Attractiveness Analysis, by End-user, 2016–2024
Figure 21: North America Facial Injectables Market Value Share Analysis, by Country, 2016 and 2024
Figure 22: North America Facial Injectables Market Attractiveness Analysis, by Country, 2016–2024
Figure 23: North America Facial Injectables Market Share Analysis, by Company, 2016 (Estimated)

List of Tables

Table 1: North America Facial Injectables Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 2: North America Collagen Market Size (US$ Mn) Forecast, 2014–2024
Table 3: North America Particle & Polymer Fillers (PPF) Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 4: North America Facial Injectables Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 5: North America Facial Injectables Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 6: North America Facial Injectables Market Size (US$ Mn) Forecast, by Country, 2014–2024

North America Facial Injectables Market: Overview

This report on the North America facial injectables market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the North America facial injectables market.

North America Facial Injectables Market: Research Methodology

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the North America facial injectables market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as growing global obsession with physical appearance and the desire to look young and rising inclination toward minimally invasive surgeries, in historical year-on-year growth have been taken into consideration while estimating the market size.

North America Facial Injectables Market: Segmentation

Based on product type, the North America facial injectables market has been segmented into Product Type – Botulinum Toxin; Hyaluronic Acid; Collagen: Porcine/ Bovine based & Human based; Particle & Polymer Fillers (PPF): Polymethylmethacrylate Beads (PMMA microspheres), Poly-L-Lactic Acid & Calcium Hydroxyapatite). The market has been further studied from the point of view of major treatment types. Based on treatment type, the market has been categorized into facial pain, wrinkle treatment, lip augmentation and others. Based on end users, the market has been segmented into hospitals, ambulatory surgical centers, cosmetic centers, dermatology clinics and physician clinics.

North America Facial Injectables Market: Regional Outlook

Geographically, the North America facial injectables market has been segmented into: the U.S. & Canada. The report also profiles major players in the facial injectables market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments.

Key Players Mentioned in this Report are:

Key companies profiled in the report Allergan Plc., Galderma S.A. (Nestle), Merz Pharma & Co. KGaA, Prollenium Medical Technologies Inc., Ipsen Group and Bloomage BioTechnology Corporation Limited.

The North America facial injectables market has been segmented as follows:

North America Facial Injectables Market, by Product Type

  • Botulinum Toxin
  • Hyaluronic Acid
  • Collagen
    • Porcine/ Bovine-Based
    • Human Based
  • Particle & Polymer Fillers (PPF)
    • Polymethylmethacrylate Beads (PMMA microspheres)
    • Poly-L-Lactic Acid
    • Calcium Hydroxyapatite

North America Facial Injectables Market, by Treatment

  • Facial Pain
  • Wrinkle Treatment
  • Lip Augmentation
  • Others

North America Facial Injectables Market, by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cosmetic Centers
  • Dermatology Clinics
  • Physician Clinics

North America Facial Injectables Market, by Country

  • North America
    • U.S.
    • Canada


 
 
Back To Top